Document is current
Any future updates will be listed below
-
Authors
Kamiunten, Ayako
Kameda, Takuro https://orcid.org/0000-0003-0100-1710
Sekine, Masaaki
Kawano, Hiroshi
Toyama, Takanori
Akizuki, Keiichi
Kawano, Noriaki
Maeda, Kouichi
Sato, Seiichi
Takeuchi, Masanori
Ishizaki, Junzo
Nagamine, Koshiro
Kuroki, Ayuka
Ikeda, Ryoma
Matsumoto, Kengo
Karasawa, Masayoshi
Tahira, Yuki
Uchida, Taisuke
Shimoda, Haruko
Hidaka, Tomonori
Yamashita, Kiyoshi
Yamaguchi, Hideki
Kubuki, Yoko
Shimoda, Kazuya
Shide, Kotaro
-
Funding
Funding for this research was provided by:
University of Miyazaki Hospital (Grant-in-Aid for Clinical Research (R6))
- License Information
-
More Information
Article History
Received: 17 October 2024
Revised: 26 February 2025
Accepted: 27 February 2025
First Online: 11 March 2025
Declarations
:
: K. Shimoda received consulting fees from Novartis Pharma, Takeda Pharmaceutical, and Bristol-Myers, all outside the submitted work, and received research grants from Perseus Proteomics, Pharma Essentia Japan KK, AbbVie GK, Astellas Pharma, MSD, Chugai Pharmaceutical, Kyowa Kirin, Pfizer, Novartis Pharma, Otsuka Pharmaceutical, Meiji Seika Pharma, and Asahi Kasei Medical, all outside the submitted work.
